768 related articles for article (PubMed ID: 27756009)
21. Thermal potentiation of chemotherapy by magnetic nanoparticles.
Torres-Lugo M; Rinaldi C
Nanomedicine (Lond); 2013 Oct; 8(10):1689-707. PubMed ID: 24074390
[TBL] [Abstract][Full Text] [Related]
22. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
23. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
Amiri M; Salavati-Niasari M; Akbari A
Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
[TBL] [Abstract][Full Text] [Related]
24. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
25. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
26. Cell-Promoted Nanoparticle Aggregation Decreases Nanoparticle-Induced Hyperthermia under an Alternating Magnetic Field Independently of Nanoparticle Coating, Core Size, and Subcellular Localization.
Mejías R; Hernández Flores P; Talelli M; Tajada-Herráiz JL; Brollo MEF; Portilla Y; Morales MP; Barber DF
ACS Appl Mater Interfaces; 2019 Jan; 11(1):340-355. PubMed ID: 30525392
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agent.
Minaei SE; Khoei S; Khoee S; Mahdavi SR
Life Sci; 2022 Oct; 306():120729. PubMed ID: 35753439
[TBL] [Abstract][Full Text] [Related]
28. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.
Tao C; Zhu Y
Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592
[TBL] [Abstract][Full Text] [Related]
29. Mean-field and linear regime approach to magnetic hyperthermia of core-shell nanoparticles: can tiny nanostructures fight cancer?
Carrião MS; Bakuzis AF
Nanoscale; 2016 Apr; 8(15):8363-77. PubMed ID: 27046437
[TBL] [Abstract][Full Text] [Related]
30. On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia.
Bellizzi G; Bucci OM
Int J Hyperthermia; 2010; 26(4):389-403. PubMed ID: 20210609
[TBL] [Abstract][Full Text] [Related]
31. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
32. In vivo applications of magnetic nanoparticle hyperthermia.
Hilger I
Int J Hyperthermia; 2013 Dec; 29(8):828-34. PubMed ID: 24219800
[TBL] [Abstract][Full Text] [Related]
33. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
Rodrigues HF; Mello FM; Branquinho LC; Zufelato N; Silveira-Lacerda EP; Bakuzis AF
Int J Hyperthermia; 2013 Dec; 29(8):752-67. PubMed ID: 24138472
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium-doped iron oxide nanoparticles induced magnetic field hyperthermia combined with radiotherapy increases tumour response by vascular disruption and improved oxygenation.
Jiang PS; Tsai HY; Drake P; Wang FN; Chiang CS
Int J Hyperthermia; 2017 Nov; 33(7):770-778. PubMed ID: 28540811
[TBL] [Abstract][Full Text] [Related]
35. Progress in the delivery of nanoparticle constructs: towards clinical translation.
Ryan SM; Brayden DJ
Curr Opin Pharmacol; 2014 Oct; 18():120-8. PubMed ID: 25450066
[TBL] [Abstract][Full Text] [Related]
36. A smart magnetic nanoplatform for synergistic anticancer therapy: manoeuvring mussel-inspired functional magnetic nanoparticles for pH responsive anticancer drug delivery and hyperthermia.
Sasikala AR; GhavamiNejad A; Unnithan AR; Thomas RG; Moon M; Jeong YY; Park CH; Kim CS
Nanoscale; 2015 Nov; 7(43):18119-28. PubMed ID: 26471016
[TBL] [Abstract][Full Text] [Related]
37. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
Liu XL; Ng CT; Chandrasekharan P; Yang HT; Zhao LY; Peng E; Lv YB; Xiao W; Fang J; Yi JB; Zhang H; Chuang KH; Bay BH; Ding J; Fan HM
Adv Healthc Mater; 2016 Aug; 5(16):2092-104. PubMed ID: 27297640
[TBL] [Abstract][Full Text] [Related]
39. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
[TBL] [Abstract][Full Text] [Related]
40. Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells.
Mansur AAP; Mansur HS; Leonel AG; Carvalho IC; Lage MCG; Carvalho SM; Krambrock K; Lobato ZIP
J Mater Chem B; 2020 Aug; 8(32):7166-7188. PubMed ID: 32614035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
